Assessing the performances of a chatbot to collect real-life data of patients suffering from primary headache disorders
- PMID: 35531091
- PMCID: PMC9069599
- DOI: 10.1177/20552076221097783
Assessing the performances of a chatbot to collect real-life data of patients suffering from primary headache disorders
Abstract
Background: There are many scales for screening the impact of a disease. These scales are generally used to diagnose or assess the type and severity of a disease and are carried out by doctors. The chatbot helps patients suffering from primary headache disorders through personalized text messages. It could be used to collect patient-reported outcomes.
Objective: The aims of this study were (1) to study whether the collection and analysis of remote scores, without prior medical intervention, are possible by a chatbot, (2) to perform suggested diagnosis and define the type of headaches, and (3) to assess the patient satisfaction and engagement with the chatbot.
Method: Voluntary users of the chatbot were recruited online. They had to be over 18 and have a personal history of headaches. A questionnaire was presented (1) by text messages to the participants to evaluate migraines (2) based on the criteria of the International Headache Society. Then, the Likert scale (3) was used to assess overall satisfaction with the use of the chatbot.
Results: We included 610 participants with primary headache disorders. A total of 89.94% (572/610) participants had fully completed the questionnaire (eight items), 4.72% (30/610) had partially completed it, and 5.41% (33) had refused to complete it. Statistical analysis was performed on 86.01% (547/610) of participants. Auto diagnostic showed that 14.26% (78/547) participants had a tension headache, and 85.74% (469/547) had a probable migraine. In this population, 15.78% (74/469) suffered from migraine without probable aura, and 84.22% (395/469) had migraine without aura. The patient's age had a significant incidence regarding the auto diagnosis (P = .008<.05). The evaluation of overall satisfaction shows that a total of 93.9% (599/610) of users were satisfied or very satisfied regarding the timeliness of responses the chatbot provides.
Conclusion: The study confirmed that it was possible to obtain such a collection remotely, and quickly (average time of 3.24 min) with a high success rate (89.67% (547/610) participants who had fully completed the IHS questionnaire). Users were strongly engaged through chatbot: out of the total number of participants, we observed a very low number of uncompleted questionnaires (6.23% (38/610)). Conversational agents can be used to remotely collect data on the nature of the symptoms of patients suffering from primary headache disorders. These results are promising regarding patient engagement and trust in the chatbot.
Keywords: Chatbot; conversational agent; patient-reported outcomes.
© The Author(s) 2022.
Figures
Similar articles
-
Usability, Engagement, and Report Usefulness of Chatbot-Based Family Health History Data Collection: Mixed Methods Analysis.J Med Internet Res. 2024 Sep 30;26:e55164. doi: 10.2196/55164. J Med Internet Res. 2024. PMID: 39348188 Free PMC article.
-
Feasibility and impact of a mental health chatbot on postpartum mental health: a randomized controlled trial.AJOG Glob Rep. 2023 Mar 29;3(3):100165. doi: 10.1016/j.xagr.2023.100165. eCollection 2023 Aug. AJOG Glob Rep. 2023. PMID: 37560011 Free PMC article.
-
Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.Clin Ther. 2007;29 Suppl:2511-9. doi: 10.1016/j.clinthera.2007.11.018. Clin Ther. 2007. PMID: 18164918
-
Outcome of juvenile headache in outpatients attending 23 Italian headache clinics. Italian Collaborative Study Group on Juvenile Headache (Società Italiana Neuropsichiatria Infantile [SINPI]).Headache. 1999 Nov-Dec;39(10):737-46. doi: 10.1046/j.1526-4610.1999.3910737.x. Headache. 1999. PMID: 11284460
-
Assessing the Feasibility of a Text-Based Conversational Agent for Asthma Support: Protocol for a Mixed Methods Observational Study.JMIR Res Protoc. 2023 Feb 2;12:e42965. doi: 10.2196/42965. JMIR Res Protoc. 2023. PMID: 36729586 Free PMC article.
Cited by
-
Overview of Chatbots with special emphasis on artificial intelligence-enabled ChatGPT in medical science.Front Artif Intell. 2023 Oct 31;6:1237704. doi: 10.3389/frai.2023.1237704. eCollection 2023. Front Artif Intell. 2023. PMID: 38028668 Free PMC article. Review.
-
Multilingual Framework for Risk Assessment and Symptom Tracking (MRAST).Sensors (Basel). 2024 Feb 8;24(4):1101. doi: 10.3390/s24041101. Sensors (Basel). 2024. PMID: 38400259 Free PMC article.
-
The first AI-based Chatbot to promote HIV self-management: A mixed methods usability study.HIV Med. 2025 Feb;26(2):184-206. doi: 10.1111/hiv.13720. Epub 2024 Oct 10. HIV Med. 2025. PMID: 39390632 Free PMC article.
-
Assessing usability of intelligent guidance chatbots in Chinese hospitals: Cross-sectional study.Digit Health. 2024 Jun 6;10:20552076241260504. doi: 10.1177/20552076241260504. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 38854920 Free PMC article.
References
-
- Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 2012; 19: 703–711. - PubMed
-
- Recommendations for clinical practice. Review of diagnosis and treatment of migraine in the adult and child October 2002. Professional recommendations and references: economic evaluation service. Rev. Neurol. (Paris) 2003; 159: S5–15. - PubMed
-
- Michel P, Pariente P, Duru G, et al. MIG ACCESS: a population-based, nationwide, comparative survey of access to care in migraine in France. Cephalalgia 1996; 16: 50–55. discussion 4. - PubMed
-
- Lanteri-Minet M, Valade D, Géraud G, et al. Prise en charge diagnostique et thérapeutique de la migraine chez l’adulte et chez l’enfant. Douleurs :Evaluation - Diagnostic - Traitement 2013; 14: 165–180. - PubMed
-
- GDB 2016 Disease and Injury and Prevalence Collaborators. Global, regional, and national incidence, prevalence and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the treatment global burden of disease study 2016. Lancet 2017; 390: 1211–1259. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous